These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Platelet-derived chemokines in inflammation and atherosclerosis. Bakogiannis C; Sachse M; Stamatelopoulos K; Stellos K Cytokine; 2019 Oct; 122():154157. PubMed ID: 29198385 [TBL] [Abstract][Full Text] [Related]
12. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Amiral J; Marfaing-Koka A; Wolf M; Alessi MC; Tardy B; Boyer-Neumann C; Vissac AM; Fressinaud E; Poncz M; Meyer D Blood; 1996 Jul; 88(2):410-6. PubMed ID: 8695787 [TBL] [Abstract][Full Text] [Related]
13. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex. Francis JL Semin Thromb Hemost; 2004 Jun; 30(3):359-68. PubMed ID: 15282659 [TBL] [Abstract][Full Text] [Related]
14. Beyond the platelet count: heparin antibodies as independent risk predictors. Stribling WK; Slaughter TF; Houle TT; Sane DC Am Heart J; 2007 Jun; 153(6):900-6. PubMed ID: 17540189 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis. Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277 [TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings. Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226 [TBL] [Abstract][Full Text] [Related]
17. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis. Look KA; Sahud M; Flaherty S; Zehnder JL Am J Clin Pathol; 1997 Jul; 108(1):78-82. PubMed ID: 9208982 [TBL] [Abstract][Full Text] [Related]
18. A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HIT. Padmanabhan A; Jones CG; Bougie DW; Curtis BR; McFarland JG; Wang D; Aster RH Thromb Haemost; 2015 Nov; 114(6):1322-3. PubMed ID: 26177881 [No Abstract] [Full Text] [Related]
19. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Jennings LK Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875 [TBL] [Abstract][Full Text] [Related]
20. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis. Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]